Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00231
|
|||||
| Drug Name |
Lysophosphatidylcholine
|
|||||
| Synonyms |
1-acetyl-sn-glycero-3-phosphocholine; 3,5,9-Trioxa-4-phosphaundecan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (R)-; AC1NSKBT; CHEBI:138424; GTPL2508; LMGP01050043; SCHEMBL19821626; [(2R)-3-acetyloxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; [(2R)-3-acetyloxy-2-hydroxypropyl] 2-trimethylazaniumylethyl phosphate
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Discovery agent [ICD11: N.A.] | Investigative | ||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C10H22NO7P
|
|||||
| Canonical SMILES |
CC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)O
|
|||||
| InChI |
InChI=1S/C10H22NO7P/c1-9(12)16-7-10(13)8-18-19(14,15)17-6-5-11(2,3)4/h10,13H,5-8H2,1-4H3/t10-/m1/s1
|
|||||
| InChIKey |
RYCNUMLMNKHWPZ-SNVBAGLBSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 299.26 | Topological Polar Surface Area | 105 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 10 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
-1.8
|
|||||
| PubChem CID | ||||||
| PubChem SID | ||||||
| ChEBI ID |
ChEBI:138424
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MFSD2A | Transporter Info | Major facilitator superfamily domain-containing protein 2A | Substrate | [1] | |
| References | ||||||
| 1 | Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature. 2014 May 22;509(7501):503-6. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.